Jennison Associates’s Alpine Immune Sciences Inc ALPN Stock Holding History

Jennison Associates’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-191,974	Closed	-$7.61M	–	619
2024 Q1	$7.61M	Buy	191,974 +50,879	+36%	+$1.5M	0.01%	415
2023 Q4	$2.69M	Buy	+141,095	New	+$1.96M	﹤0.01%	445
2016 Q4	–	Sell	-82,191	Closed	-$2.67M	–	837
2016 Q3	$2.67M	Sell	82,191 -40,993	-33%	-$998K	﹤0.01%	545
2016 Q2	$2.27M	Buy	123,184 +4	+0%	+$71	﹤0.01%	534
2016 Q1	$2.06M	Buy	123,180 +196	+0.2%	+$3.92K	﹤0.01%	531
2015 Q4	$3.81M	Sell	122,984 -14,903	-11%	-$509K	﹤0.01%	523
2015 Q3	$7.07M	Sell	137,887 -6,409	-4%	-$421K	0.01%	527
2015 Q2	$8.53M	Buy	+144,296	New	+$8.59M	0.01%	522

Jennison Associates's ALPN Position: Q2 2024 in Review

Jennison Associates sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 191,974 shares — an estimated $7.61M sold.

Jennison Associates first reported a position in ALPN in Q2 2015 and held it in 8 quarters. The position peaked at $8.53M in Q2 2015. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Jennison Associates reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Jennison Associates sold 191,974 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $7.61M.
Jennison Associates first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 8 quarters.
Jennison Associates's Alpine Immune Sciences Inc position peaked at $8.53M in Q2 2015.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.